Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jill M Herendeen"'
Autor:
Arlene S. Bridges, J. Heyward Hull, Paul B. Watkins, E. Claire Dees, Daniel L. Hertz, Christine M. Walko, Jill M Herendeen, Kristan D. Rollins
Publikováno v:
British Journal of Clinical Pharmacology. 74:197-200
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Paclitaxel and rosiglitazone are primarily metabolized by CYP2C8 and their in vitro metabolism by human liver microsomes is correlated. Probe assays that quantify the in vivo activity of CYP enzymes which
Autor:
Nikita Arya, Deborah A. Smith, Jill M Herendeen, Carolyn J. Bowen, Kevin M. Koch, Andrew P. Beelen
Publikováno v:
British journal of clinical pharmacology. 67(4)
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Lapatinib is an orally administered tyrosine kinase inhibitor indicated for use in combination with capecitabine to treat advanced or metastatic breast cancers that overexpress ErbB2 in patients previously
Autor:
Jill M Herendeen, Celeste Lindley
Publikováno v:
The Annals of pharmacotherapy. 37(11)
OBJECTIVE: To discuss the role of nonsteroidal antiinflammatory drugs (NSAIDs) in the chemoprevention of colorectal cancer. DATA SOURCES: A MEDLINE search (1966–May 2003) was performed to identify key literature. Search items included, but were not